SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU.X is trending as community members highlight its strong community, real-world utility, and increasing holder count. Many express excitement about its potential for significant growth, viewing it as a unique opportunity in the meme coin space. The community emphasizes the project's commitment to building and expanding the KENDU brand.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as community members discuss potential price movements and the recent Alpenglow upgrade, which aims to significantly boost transaction speeds.  Discussion is centered around meme coins on the Solana network, with some users highlighting projects, while others are focused on staking $SOL.X for rewards.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to a lowered full-year outlook, attributed to tariff impacts, sparking concern about future profitability. The community is debating whether the dip represents a buying opportunity or signals deeper issues with the brand and management. Some believe that external factors are temporary headwinds for this global lifestyle empire.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending following news of a partnership with OpenAI to produce AI chips, with production slated for 2026. The community is discussing the potential impact on Broadcom's revenue and its competitive positioning against Nvidia ($NVDA). Bullish sentiment is fueled by upgrades and expectations for significant growth in the AI sector, while bears express concerns about valuation.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is trending as investors analyze the potential impact of its increased revenue guidance for 2025, fueled by a collaboration agreement with Lilly. The community is actively discussing price targets from analysts, the company's financial discipline, and strategic initiatives, with some speculating about a potential acquisition. Bullish sentiment surrounds the company's strong business momentum and positive reception from analysts.

Peko is the perfect fusion between the panda, a beloved symbol in Chinese culture, and the Maneki-neko, the iconic Japanese lucky cat. This unique combination embodies prosperity, good fortune, and financial success for those who hold it.  With a distinctive collar inscribed with the name of Trump, currently the President of the United States, Peko symbolizes a message of support and optimism for the crypto world, connecting the international investment community with the belief in luck and financial opportunities.  Holding Peko means having more than just a memecoin — it’s a true digital amulet promising to attract fortune in every investment. Make Peko your partner for financial success!

PEKO

PEKO.X is gaining attention as a potential "sleeper gem" within the crypto space, prompting community discussions about its future prospects. The increase in interest is reflected in social media conversations, with many users expressing their intention to invest. The token is being mentioned alongside other prominent cryptocurrencies like BTC.X and SOL.X.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as investors discuss its potential and accessibility. The community is focused on its current market cap and potential growth. Some users are also inquiring about where to purchase the token.

Brandy was a curious blend of two well-loved icons from the Boy’s Club comics. When their digital essences combined, the result was Brandy—a creature who embodied the best of both worlds and became an inspiration for everyone. As Brandy engaged with fans, it naturally sparked discussions about everything from the latest trends to the best crypto in the market. BRANDY token launched at 20th of May 2025 is a meme token on the Solana blockchain.

BRANDY

$BRANDY.X is trending as the community discusses its potential as a 'sleeper gem' ready to 'moon,' with many highlighting the opportunity for early entry. Amidst the enthusiasm, some users are pointing out potential scam risks.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

TPST is trending as investors discuss potential catalysts, including updates to clinical trials and speculation around a possible buyout, with Roche and Bayer named as potential acquirers. Community members are analyzing technical indicators and closely watching for news, citing the company's low float and upcoming financial reports. Some traders are expressing concerns about the company's cash position and consultants now at the helm, while others highlight key milestones for potential buyout terms.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets ($SSB.X) is trending as the community anticipates potential pumps, with some highlighting a migration to Litecoin and others expressing concerns about the project's direction. Community members are actively discussing new potential gems like $BRANDY.X, $RONNIE.X, $STYLEX.X, and $MIYO.X, while also debating the legitimacy and future of SSB itself amidst conflicting claims.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Neuphoria Therapeutics Inc. soared more than 11% in premarket trading on Wednesday, propelling the micro-cap biotech stock into the top 10 trending symbols on Stocktwits.&nbsp;The company is set to receive a $15 million milestone payment from Merck, triggered by the latter's initiation of a Phase 2 clinical trial to assess the safety and efficacy of MK-1167, an experimental drug for Alzheimer's disease dementia.&nbsp;This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments, along with royalties on any licensed medicines.Investors on the platform have expressed enthusiasm, with one user speculating that the stock could reach double digits soon, while another suggested it should ideally trade at more than triple its current levels.<stembedurl>https://stocktwits.com/Tigerphoenix/message/603914417</stembedurl><stembedurl>https://stocktwits.com/Realtrader77/message/603914418</stembedurl>Neuphoria, which has a market cap of just over $7.2 million, saw an 86% jump in following over the past month and a 1,200% increase in message volume on Stocktwits in the last week.&nbsp;Earlier in the month, H.C. Wainwright raised its price target on Neuphoria to $21 from $8, maintaining a 'Buy' rating.&nbsp;The research firm said its valuation argument was based on the company's progress with its broad-spectrum anti-anxiety therapeutic, BNC210.&nbsp;According to Koyfin data, at the end of the September quarter, Neuphoria had approximately $8 million in cash and investments and total debt under $220,000.&nbsp;<a href="https://stocktwits.com/symbol/NEUP">Neuphoria's stock</a> has lost more than 63% in the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes

This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments.

Equity

This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments.


Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

NEUP
Neuphoria Therapeutics Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest NEUP News

NEUP Neuphoria Therapeutics Inc.